| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Monteagudo, María |
| dc.contributor.author | Calsina, Bruna |
| dc.contributor.author | Salazar Hidalgo, Milton |
| dc.contributor.author | Martinez Montes, Angel Mario |
| dc.contributor.author | Piñeiro-Yáñez, Elena |
| dc.contributor.author | Caleiras, Eduardo |
| dc.contributor.author | Lopez-Fernandez, Adrià |
| dc.date.accessioned | 2024-12-30T12:31:16Z |
| dc.date.available | 2024-12-30T12:31:16Z |
| dc.date.issued | 2024-12 |
| dc.identifier.citation | Monteagudo M, Calsina B, Salazar-Hidalgo ME, Martínez-Montes ÁM, Piñeiro-Yáñez E, Caleiras E, et al. MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2024 Dec;38(6):101931. |
| dc.identifier.issn | 1521-690X |
| dc.identifier.uri | https://hdl.handle.net/11351/12363 |
| dc.description | Paraganglioma; Feocromocitoma; Microambient tumoral |
| dc.description.sponsorship | This work was supported by Project PI17/01796 and PI20/01169 to M.R. [Instituto de Salud Carlos III (ISCIII), Acción Estratégica en Salud, cofinanciado a través del Fondo Europeo de Desarrollo Regional (FEDER)], Paradifference Foundation [no grant number applicable to M.R.], Pheipas Association [no grant number applicable to M.R.], Spanish National Research and Development Plan, Instituto de Salud Carlos III, and FEDER (PI20/01837 to S.R-P), and Asociación Española Contra el Cancer (AECC-LABAE20049RODR to S.R-P.). M.E.S.H is supported by ISCIII (Project: IMPaCT_VUSCan, Ref. PMP22/00064) A.M.M.M. was supported by CAM (S2017/BMD-3724; and Paradifference Foundation), M.M. and S.M. are supported by the Spanish Ministry of Science, Innovation and Universities “Formación del Profesorado Universitario— FPU” fellowship with ID number FPU18/00064, and FPU19/04940. E.A. is supported by CAM (P2022/BMD-7379, iTIRONET-CM). C.R. is supported by the CNIO Friends Postdoctoral Contract Program. A.D.T. is supported by the Centro de Investigacion Biomédica en Red de Enfermedades Raras (CIBERER). L.J.L.G. was supported by La Caixa Postdoctoral Junior Leader Fellowship (LCF/BQ/PI20/11760011). A.F.S. received the support of a fellowship from La Caixa Foundation (ID 100010434; LCF/BQ/DR21/11880009). C.M.C. was supported by a grant from the AECC Foundation (AIO15152858 MONT). F.B. and S.N. were supported as part of an Immuno-TargET project under the umbrella of University Medicine Zurich. N.B. and G.E. were financially supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within the CRC/Transregio 205/1, Project No. 314061271 - TRR205 “The Adrenal: Central Relay in Health and Disease”. |
| dc.language.iso | eng |
| dc.publisher | Elsevier |
| dc.relation.ispartofseries | Best Practice & Research Clinical Endocrinology & Metabolism;38(6) |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Tumors neuroendocrins - Aspectes genètics |
| dc.subject | Metàstasi |
| dc.subject | Tumors neuroendocrins - Tractament |
| dc.subject.mesh | Neuroendocrine Tumors |
| dc.subject.mesh | /genetics |
| dc.subject.mesh | Tumor Microenvironment |
| dc.subject.mesh | Neoplasm Metastasis |
| dc.title | MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1016/j.beem.2024.101931 |
| dc.subject.decs | tumores neuroendocrinos |
| dc.subject.decs | /genética |
| dc.subject.decs | microambiente tumoral |
| dc.subject.decs | metástasis neoplásica |
| dc.relation.publishversion | https://doi.org/10.1016/j.beem.2024.101931 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Monteagudo M] Hereditary Endocrine Cancer Group; Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain. PhD Program in Neuroscience, Universidad Autonoma de Madrid-Cajal Institute, Madrid, Spain. [Calsina B] Familial Cancer Clinical Unit, Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [Salazar-Hidalgo ME, Martínez-Montes ÁM] Hereditary Endocrine Cancer Group; Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [Piñeiro-Yáñez E] Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [Caleiras E] Histopathology Core Unit Biotechnology Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [López-Fernández A] Servei d’Oncologia Mèdica, Vall d′Hebron Hospital Universitari, Barcelona, Spain |
| dc.identifier.pmid | 39218714 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |